Showing 2 posts of 2 posts found.


Colombian government forces through near half-price cut of Novartis drug

December 21, 2016
Medical Communications, Sales and Marketing Colombia, Novartis

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …


Colombian pharma market to break $7 billion by 2020

October 24, 2016
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Colombia, market report

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …

Latest content